Psychedelic-Assisted Therapies

Results of a first-in-class clinical trial on ibogaine-magnesium therapy for Special Operations Veterans (SOV) with repeated blast exposure have been published in the journal Nature. Although preliminary, outcomes have long been awaited as they provide evidence of ibogaine’s neuro-...

Biopharma company Atai Life Sciences (NASDAQ: ATAI) shared positive results from a Phase 1 clinical study on MDMA R-enantiomer, EMP-01, under development for the potential treatment of PTSD. Assessing EMP-01's safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD...

Biopharma and resources-pooling company Atai Life Sciences (NASDAQ: ATAI) has invested a total of $50 million in Beckley Psytech Ltd., a U.K.-based clinical-stage biotech advancing short-duration psychedelics for neuropsychiatric conditions. Following the investment -$40 million direct and an...

The American Medical Association’s new coverage and reimbursement codes for FDA-legalized psychedelic-assisted therapies, the current procedural terminology (CPT) III codes, have become active for physicians and other qualified healthcare providers to apply. These are temporary codes assigned...

Once a promising pioneer state in ibogaine research for the treatment of opioid use disorder, Kentucky’s appointment of Attorney General Russell Coleman has brought about the removal of Bryan Hubbard. As chair and executive director of the Kentucky Opioid Abatement Advisory Commission (KYOAAC...

Melbourne will soon open Clarion Clinics’ first exclusively dedicated facility to provide psychedelic-assisted therapies legalized in Australia.  The subsidiary to biotech Incannex Healthcare (NASDAQ: IXHL) received the required Human Research Ethics Committee (HREC) endorsement for...

The question of whether psychedelic treatments always require psychotherapy is one hotly debated among researchers, and answers -as well as backstories- vary throughout the whole spectrum. For instance, on a recent edition of the Psychedelic Safety Seminars organized by philosopher and researcher...

Robert F. Kennedy Jr. shared his views and standpoint on psychedelics as a mental health treatment during a recent podcast interview.  The news comes at the same time as President Joe Biden’s imminent call on whether to pass a large-scale defense bill that would fund...

Biden To Decide On Psychedelic Therapy Bill President Joe Biden received the final version of a large-scale defense bill providing funding for psychedelics clinical trials for military service members. The section calls on the Department of Defense (DOD) to establish a process for active duty...

President Joe Biden received the final version of a large-scale defense bill providing funding for psychedelics clinical trials for military service members. The bill follows the Senate’s passage on Dec. 13 and House concurrence Dec. 14, reports Marijuana Moment’s Kyle Jaeger. The...

Clinical-stage psychedelics biotech Mind Medicine (MindMed) (NASDAQ: MNMD) has published new positive topline results from its Phase 2b study on a single dose of MM-120 (LSD tartrate,) with no additional therapeutic intervention, in Generalized Anxiety Disorder (GAD.)  MM-120 is the company...

A new article authored by renowned regulatory specialist Dr. Mason Marks, of the Project on Psychedelics Law and Regulation at Harvard Law School, highlights growing concern about the chasm between state-level regulations and the FDA’s stance on psychedelics. Published in the...

Canadian psychedelics biotech Tryp Therapeutics Inc. has entered into an agreement with Australian publicly-trading drug vehicle developer Exopharm Ltd. for the acquisition of 100% of Tryp’s issued and outstanding common shares.  The arm’s length transaction, dated Dec. 8...

John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy The world seemed to come to a momentary halt on December 8, 1980, when news that John Lennon was shot and killed as he approached his apartment building in New York City came out. Lennon...

Congressional lawmakers from both sides of the aisles and in both chambers agreed upon a large-scale defense bill which includes funding psychedelic studies for military service members, reported Marijuana Moment’s Kyle Jaeger. The report on the 2024 National Defense Authorization Act (...